List of Tables
Table 1. Global Oral Vaccine for Human Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Oral Vaccine for Human Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Oral Vaccine for Human Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oral Vaccine for Human Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Oral Vaccine for Human Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Oral Vaccine for Human Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Oral Vaccine for Human Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Oral Vaccine for Human Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Oral Vaccine for Human, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Vaccine for Human, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Vaccine for Human, Product Type & Application
Table 12. Global Key Manufacturers of Oral Vaccine for Human, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Vaccine for Human by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Vaccine for Human as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Vaccine for Human Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Oral Vaccine for Human Sales by Region (2020-2025) & (K Units)
Table 18. Global Oral Vaccine for Human Sales Market Share by Region (2020-2025)
Table 19. Global Oral Vaccine for Human Sales by Region (2026-2031) & (K Units)
Table 20. Global Oral Vaccine for Human Sales Market Share by Region (2026-2031)
Table 21. Global Oral Vaccine for Human Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Oral Vaccine for Human Revenue Market Share by Region (2020-2025)
Table 23. Global Oral Vaccine for Human Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Oral Vaccine for Human Revenue Market Share by Region (2026-2031)
Table 25. North America Oral Vaccine for Human Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Oral Vaccine for Human Sales by Country (2020-2025) & (K Units)
Table 27. North America Oral Vaccine for Human Sales by Country (2026-2031) & (K Units)
Table 28. North America Oral Vaccine for Human Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Oral Vaccine for Human Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Oral Vaccine for Human Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Oral Vaccine for Human Sales by Country (2020-2025) & (K Units)
Table 32. Europe Oral Vaccine for Human Sales by Country (2026-2031) & (K Units)
Table 33. Europe Oral Vaccine for Human Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Oral Vaccine for Human Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Oral Vaccine for Human Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Oral Vaccine for Human Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Oral Vaccine for Human Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Oral Vaccine for Human Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Oral Vaccine for Human Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oral Vaccine for Human Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Oral Vaccine for Human Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Oral Vaccine for Human Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Oral Vaccine for Human Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oral Vaccine for Human Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Oral Vaccine for Human Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Oral Vaccine for Human Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Oral Vaccine for Human Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Oral Vaccine for Human Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Oral Vaccine for Human Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Oral Vaccine for Human Sales (K Units) by Type (2020-2025)
Table 51. Global Oral Vaccine for Human Sales (K Units) by Type (2026-2031)
Table 52. Global Oral Vaccine for Human Sales Market Share by Type (2020-2025)
Table 53. Global Oral Vaccine for Human Sales Market Share by Type (2026-2031)
Table 54. Global Oral Vaccine for Human Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Oral Vaccine for Human Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Oral Vaccine for Human Revenue Market Share by Type (2020-2025)
Table 57. Global Oral Vaccine for Human Revenue Market Share by Type (2026-2031)
Table 58. Global Oral Vaccine for Human Price (US$/Unit) by Type (2020-2025)
Table 59. Global Oral Vaccine for Human Price (US$/Unit) by Type (2026-2031)
Table 60. Global Oral Vaccine for Human Sales (K Units) by Application (2020-2025)
Table 61. Global Oral Vaccine for Human Sales (K Units) by Application (2026-2031)
Table 62. Global Oral Vaccine for Human Sales Market Share by Application (2020-2025)
Table 63. Global Oral Vaccine for Human Sales Market Share by Application (2026-2031)
Table 64. Global Oral Vaccine for Human Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Oral Vaccine for Human Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Oral Vaccine for Human Revenue Market Share by Application (2020-2025)
Table 67. Global Oral Vaccine for Human Revenue Market Share by Application (2026-2031)
Table 68. Global Oral Vaccine for Human Price (US$/Unit) by Application (2020-2025)
Table 69. Global Oral Vaccine for Human Price (US$/Unit) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Merck Oral Vaccine for Human Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. GSK Oral Vaccine for Human Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sanofi Oral Vaccine for Human Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Lanzhou Institute Company Information
Table 86. Lanzhou Institute Description and Business Overview
Table 87. Lanzhou Institute Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Lanzhou Institute Oral Vaccine for Human Product
Table 89. Lanzhou Institute Recent Developments/Updates
Table 90. Serum Institute Company Information
Table 91. Serum Institute Description and Business Overview
Table 92. Serum Institute Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Serum Institute Oral Vaccine for Human Product
Table 94. Serum Institute Recent Developments/Updates
Table 95. Valneva Company Information
Table 96. Valneva Description and Business Overview
Table 97. Valneva Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Valneva Oral Vaccine for Human Product
Table 99. Valneva Recent Developments/Updates
Table 100. Shanghai United Cell Company Information
Table 101. Shanghai United Cell Description and Business Overview
Table 102. Shanghai United Cell Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Shanghai United Cell Oral Vaccine for Human Product
Table 104. Shanghai United Cell Recent Developments/Updates
Table 105. Bibcol Company Information
Table 106. Bibcol Description and Business Overview
Table 107. Bibcol Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Bibcol Oral Vaccine for Human Product
Table 109. Bibcol Recent Developments/Updates
Table 110. PaxVax Company Information
Table 111. PaxVax Description and Business Overview
Table 112. PaxVax Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. PaxVax Oral Vaccine for Human Product
Table 114. PaxVax Recent Developments/Updates
Table 115. Vabiotech Company Information
Table 116. Vabiotech Description and Business Overview
Table 117. Vabiotech Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Vabiotech Oral Vaccine for Human Product
Table 119. Vabiotech Recent Developments/Updates
Table 120. Tiantan Biological Company Information
Table 121. Tiantan Biological Description and Business Overview
Table 122. Tiantan Biological Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Tiantan Biological Oral Vaccine for Human Product
Table 124. Tiantan Biological Recent Developments/Updates
Table 125. EuBiologics Company Information
Table 126. EuBiologics Description and Business Overview
Table 127. EuBiologics Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. EuBiologics Oral Vaccine for Human Product
Table 129. EuBiologics Recent Developments/Updates
Table 130. Panacea Biotec Ltd Company Information
Table 131. Panacea Biotec Ltd Description and Business Overview
Table 132. Panacea Biotec Ltd Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Panacea Biotec Ltd Oral Vaccine for Human Product
Table 134. Panacea Biotec Ltd Recent Developments/Updates
Table 135. Bio-Med Company Information
Table 136. Bio-Med Description and Business Overview
Table 137. Bio-Med Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Bio-Med Oral Vaccine for Human Product
Table 139. Bio-Med Recent Developments/Updates
Table 140. Halfkin Bio-Pharmaceuticals Company Information
Table 141. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 142. Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Product
Table 144. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Oral Vaccine for Human Distributors List
Table 148. Oral Vaccine for Human Customers List
Table 149. Oral Vaccine for Human Market Trends
Table 150. Oral Vaccine for Human Market Drivers
Table 151. Oral Vaccine for Human Market Challenges
Table 152. Oral Vaccine for Human Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Vaccine for Human
Figure 2. Global Oral Vaccine for Human Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oral Vaccine for Human Market Share by Type: 2024 & 2031
Figure 4. Rotavirus Vaccine Product Picture
Figure 5. Cholera Vaccine Product Picture
Figure 6. Oral Polio Vaccine Product Picture
Figure 7. Other Product Picture
Figure 8. Global Oral Vaccine for Human Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Oral Vaccine for Human Market Share by Application: 2024 & 2031
Figure 10. Public
Figure 11. Private
Figure 12. Global Oral Vaccine for Human Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Oral Vaccine for Human Market Size (2020-2031) & (US$ Million)
Figure 14. Global Oral Vaccine for Human Sales (2020-2031) & (K Units)
Figure 15. Global Oral Vaccine for Human Average Price (US$/Unit) & (2020-2031)
Figure 16. Oral Vaccine for Human Report Years Considered
Figure 17. Oral Vaccine for Human Sales Share by Manufacturers in 2024
Figure 18. Global Oral Vaccine for Human Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Oral Vaccine for Human Players: Market Share by Revenue in Oral Vaccine for Human in 2024
Figure 20. Oral Vaccine for Human Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Oral Vaccine for Human Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Oral Vaccine for Human Sales Market Share by Country (2020-2031)
Figure 23. North America Oral Vaccine for Human Revenue Market Share by Country (2020-2031)
Figure 24. United States Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Oral Vaccine for Human Sales Market Share by Country (2020-2031)
Figure 27. Europe Oral Vaccine for Human Revenue Market Share by Country (2020-2031)
Figure 28. Germany Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Oral Vaccine for Human Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Oral Vaccine for Human Revenue Market Share by Region (2020-2031)
Figure 35. China Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Oral Vaccine for Human Sales Market Share by Country (2020-2031)
Figure 43. Latin America Oral Vaccine for Human Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Oral Vaccine for Human Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Oral Vaccine for Human Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Oral Vaccine for Human Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Oral Vaccine for Human by Type (2020-2031)
Figure 53. Global Revenue Market Share of Oral Vaccine for Human by Type (2020-2031)
Figure 54. Global Oral Vaccine for Human Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Oral Vaccine for Human by Application (2020-2031)
Figure 56. Global Revenue Market Share of Oral Vaccine for Human by Application (2020-2031)
Figure 57. Global Oral Vaccine for Human Price (US$/Unit) by Application (2020-2031)
Figure 58. Oral Vaccine for Human Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
